Group 1 - The company plans to implement a restricted stock incentive plan for 2025 [1] - The company conducted a self-examination of insider trading activities related to the incentive plan, confirming no violations occurred during the specified period [2] - The company ensured that all insider information was properly managed and disclosed, with no evidence of information leakage [2] Group 2 - The self-examination covered insider information personnel who were registered and monitored according to regulations [2] - The company obtained verification documents from China Securities Depository and Clearing Corporation Limited, confirming no stock trading by the insider information personnel during the self-examination period [2] - The board of directors guarantees the accuracy and completeness of the information disclosed [1]
美好医疗: 关于2025年限制性股票激励计划内幕信息知情人买卖公司股票情况的自查报告